Functional testosterone: Biochemical assessment of hypogonadism in men - Report from a multidisciplinary workshop hosted by the Ontario Society of Clinical Chemists

Aging Male

Volumn 10, Issue 4, 2007, Pages 211-216

  Collier, C P ^a   Clark, A F ^a   Bain, J ^b   Godwin, M ^a,g   Hudson, R W ^a   Lepage, R ^c   Morales, A ^a   Moses, G ^d,f   Tremblay, R R ^e   Vandenberghe, H ^f,h  

^a QUEEN S UNIVERSITY   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MDS Laboratories   (Canada)

^e LAVAL UNIVERSITY   (Canada)

^f DYNACARE LABORATORIES   (Canada)

^g MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^h ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Calculated bioavailable testosterone; Expert opinion; Hypogonadism; Men; Position statement; Testosterone

Indexed keywords

SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ARTICLE; AUTOANALYSIS; BIOAVAILABILITY; BIOCHEMISTRY; CALCULATION; CANADA; CLINICAL CHEMISTRY; ENDOCRINOLOGY; EQUILIBRIUM DIALYSIS; EXPERT SYSTEM; FAMILY MEDICINE; FOLLOW UP; HUMAN; HYPOGONADISM; MALE; MEDICAL RESEARCH; MEDICAL SPECIALIST; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RELIABILITY; SEX HORMONE DETERMINATION; STANDARDIZATION; UROLOGY;

BIOLOGICAL AVAILABILITY; CHEMISTRY, CLINICAL; CLINICAL CHEMISTRY TESTS; HUMANS; HYPOGONADISM; MALE; ONTARIO; SEX HORMONE-BINDING GLOBULIN; SOCIETIES; TESTOSTERONE;

EID: 36348955116     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.1080/13685530701600802     Document Type: Article

References (33)

1. Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM, McKinlay JB. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts male aging study. J Clin Endocrinol Metab 2004;89:5920-5926.
2. Tariq SH, Haren MT, Kim MJ, Morley JE. Andropause: Is the emperor wearing any clothes? Rev Endo Metab Dis 2005;6:77-84.
3. Tremblay RR, Gagne JM. Can we get away from serum total testosterone in the diagnosis of andropause? The Aging Male 2005;8:147-150.
4. Morales A. Andropause (or symptomatic late-onset hypogonadism): facts, fiction and controversies. The Aging Male 2004;7:1-7.
5. Morales A, Buvat J, Gooren LJ, Guay AT, Kaufman JM, Tan HM, Torres LO. Endocrine aspects of sexual dysfunction in men. J Sexual Medicine 2004;1:69-81.
6. Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morley JE, Schulman C, Wang C, Weidner W, Wu CW. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. J Androl 2006;27:135-137.
7. Bain J. Andropause: Testosterone replacement therapy for aging men. Can Fam Physician 2001;47:91-97.
8. Isidori AM, Lenzi A. Risk factors for androgen decline in older males: Lifestyle, chronic diseases and drugs. J Endocrinol Invest 2005;28(Suppl to no. 3):14-22.
9. Longcope C, Feldman HA, McKinlay JB, Araujo AB. Diet and sex hormone binding globulin. J Clin Endocrinol Metab 2000;85:293-296.
10. Diver MJ. Analytical and physiological factors affecting the interpretation of serum testosterone concentration in men. Ann Clin Biochem 2006;43:3-12.
11. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocrine Reviews 2005;26(6):833-876.
12. Allan CA, McLachlan RI. Age-related changes in testosterone and the role of replacement therapy in older men. Clin Endocrinol 2004;60:653-670.
13. Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease and changing sex hormone levels in middle-aged men: results of the Massachusetts male aging study. J Clin Endocrinol Metab 1991;73:1016-1025.
14. Diver MJ, Imtiaz KE, Ahmad AM, Vora JP, Fraser WD. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol 2003;58:710-717.
15. Matsumoto A, Bremner W. Editorial: Serum testosterone assays-accuracy matters. J Clin Endocrinol Metab 2004;89:520-524.
16. Morley JE, Ping P, Perry (III) HM. Evaluation of assays available to measure free testosterone. Metabolism 2002;51:554-559.
17. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. POSITION STATEMENT: Utility, limitations, and pitfalls in measuring testosterone: An endocrine society position statement. J Clin Endocrinol Metab 2007;92:405-413.
18. Gheorghiu I, Moshyk A, Lepage R, Ahnadi CE, Grant AM. When is bioavailable testosterone a redundant test in the diagnosis of hypogonadism in men? Clin Biochem 2005;38:813-818.
19. Lepage R. Measurement of testosterone and its sub-fractions in Canada. Clin Biochem 2006;39:97-108.
20. Morris PD, Malkin CJ, Channer KS, Jones TH. A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men. Eur J Endocrinol 2004;151:241-249.
21. Rosner W. An extraordinarily inaccurate assay for free testosterone is still with us. J Clin Endocrinol Metab 2001;86:2903.
22. Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N, Lacroix I, Somma-Delpero C, Boudou P. Testosterone measured by 10 Immunoassays and by isotopedilution gas chromatography-mass spectrometry in sera from 116 men, women and children. Clin Chem 2003;49:1381-1395.
23. Wang C, Catlin DH, Demers LM, Starcevic B, Swerdloff RS. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectroscopy. J Clin Endocrinol Metab 2004;89:534-543.
24. Emadi-Konjin P, Bain J, Bromberg IL. Evaluation of an algorithm for calculation of serum "bioavailable" testosterone (BAT). Clin Biochem 2003;36:591-596.
25. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672.
26. Snyder PJ, Peachey H, Berlin JA, Hannoush P. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 2000;85:2670-2677.
27. Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L, Swerdloff RS. Long-term testosterone gel (Androgel) treatment etc. J Clin Endocrinol Metab 2004;89:2085-2098.
28. Kelleher S, Conway AJ, Handelsman DJ. Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab 2004;89:3813-3817.
29. Malkin CJ, Pugh PJ, Jones RD, Jones TH, Channer KS. Testosterone as a protective factor against atherosclerosis - immunomodulation and influence upon plaque development and stability. J Endocrinol 2003;178:373-380.
30. Black AM, Day AG, Morales A. The reliability of clinical and biochemical assessment in symptomatic late-onset hypogonadism: can a case be made for a 3-month therapeutic trial? BJU International 2004;94:1066-1070.
31. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2006;91:1995-2010.
32. Shames D, Gassman A, Handelsman H. COMMENTARY: Guideline for male testosterone therapy: A regulatory perspective. J Clin Endocrinol Metab 2007;92(2):414-415.
33. Haren M, Chapman I, Coates P, Morley J, Wittert G. Effect of 12 month oral testosterone on testosterone deficiency symptoms in symptomatic elderly males with low-normal gonadal status. Age and Aging 2005;34:125-130.